Short answer: no. Recreational marijuana is still a Schedule I controlled substance under federal law as of November 2, 2026, so you cannot treat marijuana as federally legal for non-medical use. The final order published April 28, 2026 moved only FDA-approved marijuana products and marijuana covered by a qualifying state medical license to Schedule III. On October 30, 2026, the Justice Department announced that DEA is issuing its first federal registrations to medical dispensaries, and those registrations cover medical activity only.
| Recreational marijuana | Schedule I under federal law. The April 2026 order does not authorize it. |
| Medical marijuana | Moved to Schedule III only for FDA-approved products and marijuana under a qualifying state medical license. |
| DEA registrations | First phase announced October 30, 2026: more than 900 dispensaries in Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia. |
| Timely window | April 28 to June 26, 2026. This is the expedited or timely window. |
| Supply chain deadline | November 29, 2026, for timely applicants to finish verification and set up compliant supply chains. |
| Broader rescheduling hearing | On hold until at least November 5, 2026. |
| Registered dispensary names | Not public. DOJ has not named them. |
| Status as of | November 2, 2026. |
Is marijuana federally legal for recreational use?
No. Recreational marijuana remains Schedule I under federal law. The Justice Department’s final order covers a defined set of medical activities, and recreational use falls outside it. Marijuana outside the order’s scope stays under Schedule I controls, and broader rescheduling is being considered in a separate administrative proceeding.
State law is a separate question. The Associated Press reports that two dozen states plus Washington, D.C. have authorized adult use. MJBizDaily reports that adult-use cannabis remains Schedule I while a separate process plays out, with no clear timeline. State permission does not change the federal schedule for recreational use.
Why isn’t marijuana federally legal?
Because federal law still places marijuana in Schedule I, and the April order carved out only a narrow medical category. Marijuana Moment notes that state recreational programs do not use doctors’ written certifications, so it is unclear how adult-use businesses could register even if broader rescheduling is adopted.
What is still illegal federally after rescheduling?
The April order changed the federal status of a narrow group of medical products and left the rest of marijuana where it was. As of November 2, 2026, the official documents and reporting describe the following:
| Activity | Federal status as of November 2, 2026 |
|---|---|
| Recreational (adult-use) marijuana, including products sold under state adult-use programs | Remains Schedule I. The order does not authorize it, and broader rescheduling is a separate proceeding. |
| Non-medical manufacture, distribution, dispensing or use under a DEA registration | Not covered. A registration does not authorize non-medical activity. |
| Medical marijuana outside the order’s scope or without a qualifying state medical license | Remains Schedule I. |
| Schedule III medical dealings between a timely applicant or registrant and an entity that did not apply in the window or has not applied | DEA’s guidance says these may not lawfully occur until that entity becomes a DEA registrant. Dealing with anyone else could be grounds for denial of a timely application or revocation of a registration. |
| Illegal marijuana trafficking | DOJ says it will keep prosecuting illegal marijuana trafficking and related criminal activity under federal law, according to Attorney General Todd Blanche. |
| Licenses that combine medical and non-medical dispensing (dual-purpose licenses) | DEA issued an order to show cause to a Minnesota business holding a dual-purpose license, stating that such a license falls outside the definition of a state medical marijuana license. |
What does a DEA registration allow, and what does it not allow?
DOJ’s final order says a registered dispenser may dispense to people authorized by state law to possess marijuana for medical purposes, within the limits of its state license. The same order says a registration does not authorize manufacture, distribution, dispensing or use for non-medical purposes.
A registration is tied to the state license. If a state medical marijuana license is suspended, revoked or expires, the DEA registration is automatically suspended. DOJ also says registered dispensaries remain subject to federal requirements for security, recordkeeping, inventory controls and other safeguards. Each dispensary had to complete DEA’s pre-registration investigation before it was registered.
What do the April 28 to June 26, 2026 dates mean?
April 28 to June 26, 2026 is the timely window. DEA’s October 30 guidance counts as timely applicants the entities that submitted a complete application, including the registration fee, in that window. It leaves out applicants who withdrew, applicants denied by a final order, and applicants without the required state medical license.
Cannabis Business Times reports that DEA opened a new Schedule III registration portal for manufacturers, distributors and labs in October, and that DEA will not prioritize those applications until it has processed timely applicants.
Timely applicants can dispense, manufacture or distribute schedule III medical marijuana under their state license while their applications are pending. They can also deal with other timely applicants and with DEA registrants.
Can a registered or timely business deal with businesses that did not apply?
DEA’s guidance says timely applicants and registrants may not lawfully engage in schedule III medical marijuana activity with entities that did not apply between April 28 and June 26, 2026, or that have not applied, until those entities become DEA registrants. It also says dealing with anyone else could be grounds for denial of a timely application or revocation of a registration.
The guidance lists the due diligence it generally expects. For a dispenser, that means a copy of its Marijuana Dispensary Information Submission confirmation and verification of its document control number (DCN) on DEA’s Diversion Control website. Manufacturers and distributors follow the same DCN verification. Registrants supply a copy of their certificate of registration, and each entity supplies a copy of its state license and proof that the license is active. The DCN check is a due-diligence step for businesses dealing with timely applicants. It is not a consumer lookup tool.
DEA expects timely applicants to finish verification and set up compliant supply chains by November 29, 2026. Timely dispenser and distributor applicants may keep possessing, dispensing and distributing inventory they acquired before the guidance was issued, including inventory from entities that do not qualify. That inventory provision names dispensers and distributors, not manufacturers.
On laboratories, the guidance says DEA does not intend to penalize registrants and timely applicants for sending de minimis quantities to a non-registered analytical lab in the same state, if detailed records are kept and the conditions in the guidance are met. It does not permit receiving medical marijuana from a non-registered lab. The guidance states that it does not have the force of law and is not meant to bind the public.
How many businesses are registered, and in which states?
DOJ’s October 30 release says the first registrations include more than 900 dispensaries across Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia. Manufacturer and distributor applications are still under review, including facility inspections, production controls and quota determinations.
Applying is not the same as being registered. Cannabis Business Times reports that DEA released a list of nearly 7,000 timely applicants on October 30: 4,197 dispensaries, 2,086 manufacturers and 710 distributors. That list gives business types and states, not business names. The largest state counts it reports were:
| State | Timely applicants (Cannabis Business Times count) |
|---|---|
| Oklahoma | 2,442 |
| Florida | 812 |
| California | 771 |
| Maine | 320 |
| Pennsylvania | 227 |
| Missouri | 209 |
The other 23 adult-use states together account for nearly 2,800 timely applicants, according to the same report, including 1,769 dispensaries. Virginia has legalized adult use but has no licensed adult-use market yet.
Are the registered dispensaries named anywhere?
No. DOJ’s release does not name the registered businesses, and the Associated Press reports the department did not immediately identify them. The names of the registered dispensaries are not public, and DOJ has not named them. The timely applicant list shows business types and states only, so it does not tell you which dispensary holds a registration. The DCN check described above is a due-diligence step for businesses, not a lookup tool for consumers.
What happened in Minnesota?
Minnesota is the clearest example so far of the dual-license question. The Minnesota Star Tribune reports that DEA agents delivered an order to a Minneapolis dispensary on October 30. The document is an order to show cause, signed by Cheri Oz, assistant administrator of DEA’s Diversion Control Division, as Marijuana Moment reports.
The order says Minnesota’s dual-purpose license, which permits both medical and non-medical dispensing, falls outside the definition of a state medical marijuana license, and that the state does not provide the robust diversion protections the rule calls for. It points to veterans who can self-certify with an identification and an attestation. It also says Minnesota permits dispensaries to dispense hemp-derived cannabinoids, which it calls synthetic marijuana products. The Star Tribune reports that none of the listed reasons concerned a violation of state law.
The order gives the business two options: request a hearing before an administrative law judge within 30 days, or submit a corrective action plan. Under DEA’s guidance, an application ends only by withdrawal or by a final order denying it. An order to show cause is not a settled denial, and its outcome is not yet known.
Minnesota’s Office of Cannabis Management says the letter does not affect the state law that authorizes its medical and adult-use programs, and that medical cannabis remains available to patients. Cannabis Business Times reports that 30 Minnesota businesses, 26 of them dispensaries, filed timely applications, and that the state’s other 300-plus dispensary licensees stayed out of the expedited process.
Some coverage calls the Minnesota document a denial, or says DEA rejected all dual-license applicants. The published document is one order to show cause. The Star Tribune quotes the business owner saying agents told him they were serving many others with the same document that day. The Cannabis Regulators Association said orders went to businesses in a wide range of states, including some that have only legalized medical cannabis, and that state regulators received no notice. No count has been published.
Will marijuana become federally legal soon, or in 2026?
As of November 2, 2026, no date has been announced for a final decision on broader rescheduling, and no clear timeline has been set. Cannabis Business Times reports that the broader rescheduling hearing ran 11 days and concluded July 15, 2026. On October 22, DEA’s chief administrative law judge declined to reopen it for new testimony after a September 23 Government Accountability Office report found gaps in DEA scheduling policies. The judge admitted the report and set briefs due October 29 and replies due November 5. The process is on hold until at least November 5.
After that, the judge must certify the record and make a nonbinding recommendation to DEA Administrator Terry Cole. For background on what that hearing could address, see the what could change at the DEA hearing analysis. The marijuana rescheduling order analysis covers the April order and its deadlines.
Marijuana Moment notes that it is unclear how adult-use businesses could register even if broader rescheduling is adopted, because those programs do not use doctors’ written certifications.
How would marijuana become federally legal, and why do supporters want it?
The route in front of federal regulators right now is the separate administrative proceeding on broader rescheduling. That is the only route the official actions described above cover.
The Cannabis Regulators Association lists as unresolved how DEA will buy and resell marijuana, how it will work with states, and what it will prioritize in enforcement. The Associated Press reports it remains unclear what requirements DEA may impose, including on owners with criminal histories.
Supporters point to patient access and tax treatment. Steph Sherer of Americans for Safe Access called the registrations “a tremendous victory for patient access.” Attorney General Todd Blanche said regulated distribution by registered applicants would help broaden access to chronic pain treatment and public safety. Chris Lindsey of the American Trade Association for Cannabis and Hemp said the industry is watching what the newly registered companies will do next.
Does rescheduling change taxes for marijuana businesses?
Treasury’s April 23, 2026 press release says Section 280E generally disallows deductions and credits for a business that consists of trafficking in Schedule I or II substances. Rescheduling generally removes that bar for businesses that, because of the order, no longer traffic in those substances. Treasury expects guidance to clarify that, for businesses with several activities, 280E applies only to the activities tied to Schedule I or II substances, and to include a transition rule that starts with the full taxable year that includes the order’s effective date. The Treasury release does not make DEA registration a stated condition, and it does not describe relief for earlier years.
DOJ’s final order says that, as a consequence of the rule, state licensees will no longer be subject to the 280E deduction disallowance. It also says nothing in the rule determines federal tax liability, and that qualifying state licensees should consult tax counsel. Whether Treasury has issued the expected guidance since April is not something the April release answers, and you can check Treasury’s press releases for updates.
Carol Moss, an Edina cannabis attorney, told the Star Tribune that businesses in dual-market states may miss out on the tax benefit even when they are not involved in recreational cannabis.
Does this change hemp or delta-9 products?
Vicente LLP reports that the hemp definition is a separate matter from marijuana rescheduling. H.R. 6500 moved the federal hemp total THC standard and the 0.4 milligram total THC per container limit to December 11, 2026. Public Law 119-37, signed November 12, 2025, amended the hemp definition in section 781.
For state-by-state status of delta-9 products, see the delta-9 state legal guide.
Does this affect drug tests or employment?
Drug testing is a separate subject. The dot drug tests and marijuana rescheduling guide covers how the 2026 changes relate to DOT testing.
Which states allow marijuana for medical use, and which ban it?
The Associated Press reports that 40 states have medical marijuana systems, eight others allow low-THC cannabis or CBD oil for medical use, and only Idaho and Kansas ban marijuana outright. Those programs operate under state law. Federal status is set separately from state law, and DOJ says a state license alone does not automatically bring federal registration.
Florida is the country’s largest medical-only market, according to MJBizDaily. Florida, California, Oklahoma, Maine, Pennsylvania and Missouri had the most timely applicants by state in the Cannabis Business Times count. Because the registered dispensary names are not public, the published lists do not tell you whether a given local business holds a DEA registration.
What is still unknown?
- The names of the registered dispensaries are not public, and DOJ has not named them.
- The Associated Press reports it remains unclear what requirements DEA may impose, including on owners with criminal histories.
- The Cannabis Regulators Association lists as open questions how DEA will buy and resell marijuana, how it will work with states, and its enforcement priorities.
- No date has been announced for a final decision on broader rescheduling. The hearing process is on hold until at least November 5.
- Whether Treasury has issued the expected 280E guidance is not answered by its April release.
- The outcome of Minnesota’s order to show cause is not yet known. The business may request a hearing within 30 days or submit a corrective action plan.
- DEA will not prioritize manufacturer, distributor and lab applications until it has processed timely applicants.
Disclaimer: This is general information about federal and state marijuana law as of November 2, 2026. It is not legal advice. Agency actions and court proceedings are changing, and the status described here may change after this date.
Disclosure: This article may contain affiliate links. If you click a link and make a purchase, we may receive a commission at no additional cost to you.
By HealthDataConsortium.org Research Team
